Medindia

X

Yongye International to Present at Rodman & Renshaw Annual China Investment Conference

Tuesday, March 2, 2010 General News J E 4
Advertisement

BEIJING, March 2 /PRNewswire-Asia-FirstCall/ -- Yongye International, Inc. (Nasdaq: YONG), ("Yongye" or the "Company") a leading developer, manufacturer, and distributor of Shengmingsu brand plant and animal nutrient products in the People's Republic of China (PRC), today announced that the Company's management will present at the upcoming Rodman & Renshaw Annual China Investment Conference in Beijing.

The date, time, and location of Yongye's presentation at the Rodman & Renshaw Conference are as follows:

    Date:      March 9, 2010
    Time:      11:05 a.m. - 11:30 a.m. Beijing Time
    Presenter: Mr. Larry Gilmore, VP of Corporate Strategy
               Mr. Sam Yu, Chief Financial Officer
    Venue:     Ballroom II, The Regent Hotel, 99 Jinbao Street, Beijing, China

The Rodman & Renshaw China Annual China Investment Conference will feature more than 130 U.S.-listed Chinese companies from the Agriculture, Auto, Cleantech & Energy, Consumer/Retail, Education, Healthcare, Industrial and Technology industries. The conference is formatted to maximize investor/company interaction through a combination of company presentations, Q&A sessions and management one-on-one meetings. The gathering of presenting companies, senior management, and industry experts, as well as institutional investors, will enjoy a unique and comprehensive look at China on a global scale. Interested parties and investors may find more information about the conference by contacting info@rodman.com or calling (212) 356-0500.

About Yongye International, Inc.

Yongye International, Inc., headquartered in Beijing, is engaged in the development, manufacturing, distribution and sales of Shengmingsu brand plant and animal nutrient products. The Company's patented and patent pending formulas and proprietary extraction processes allow it to create products that increase crop yields and improve the health of livestock. Its sole operating subsidiary, Inner Mongolia Yongye Nongfeng Biotechnology Co., Ltd., is headquartered in Beijing with major operations located in Inner Mongolia, People's Republic of China. For more information, please visit the Company's website at http://www.yongyeintl.com .

Safe Harbor Statement

This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on the SEC's website (http://www.sec.gov ). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

    For more information, please contact:

    Yongye International, Inc.
     Mr. Larry Gilmore-VP of Corporate Strategy
     Phone: +86-10-8232-8866 x8880
     Email: larry.gilmore@yongyeintl.com

    CCG Investor Relations, Inc.
     Mr. Crocker Coulson, President
     Phone: +1-646-213-1915 (New York)
     Email: crocker.coulson@ccgir.com

     Athan Dounis, Account Manager
     Phone: +1-646-213-1916
     Email: athan.dounis@ccgir.com
     Web:   http://www.ccgirasia.com

SOURCE Yongye International, Inc.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Stem Cell Innovations to Provide Research and Assa...
S
Leading Health Systems Select Allscripts for Care ...